ZA200500019B - Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs - Google Patents

Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs Download PDF

Info

Publication number
ZA200500019B
ZA200500019B ZA200500019A ZA200500019A ZA200500019B ZA 200500019 B ZA200500019 B ZA 200500019B ZA 200500019 A ZA200500019 A ZA 200500019A ZA 200500019 A ZA200500019 A ZA 200500019A ZA 200500019 B ZA200500019 B ZA 200500019B
Authority
ZA
South Africa
Prior art keywords
hydroxy
composition according
pharmaceutical composition
methyl
propellant
Prior art date
Application number
ZA200500019A
Other languages
English (en)
Inventor
Michel Pairet
Christopher J M Meade
Michael P Pieper
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200500019B publication Critical patent/ZA200500019B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200500019A 2002-08-17 2005-01-03 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs ZA200500019B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10237739A DE10237739A1 (de) 2002-08-17 2002-08-17 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika

Publications (1)

Publication Number Publication Date
ZA200500019B true ZA200500019B (en) 2006-07-26

Family

ID=30775387

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500019A ZA200500019B (en) 2002-08-17 2005-01-03 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs

Country Status (21)

Country Link
EP (2) EP1530471B1 (es)
JP (1) JP2006501253A (es)
KR (1) KR101083977B1 (es)
CN (1) CN1688308A (es)
AT (1) ATE366574T1 (es)
AU (1) AU2003255289B2 (es)
BR (1) BR0313526A (es)
CA (1) CA2495454C (es)
CO (1) CO5540380A2 (es)
CY (1) CY1107742T1 (es)
DE (2) DE10237739A1 (es)
DK (1) DK1530471T3 (es)
ES (1) ES2290549T3 (es)
IL (1) IL166891A (es)
MX (1) MXPA05001823A (es)
NZ (1) NZ538834A (es)
PL (1) PL212070B1 (es)
PT (1) PT1530471E (es)
RU (1) RU2332217C2 (es)
WO (1) WO2004022058A1 (es)
ZA (1) ZA200500019B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012265A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
SI1383786T1 (sl) 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
CN101119706B (zh) 2005-02-25 2013-04-17 奇斯药制品公司 用于加压计量吸入器的包含螯合剂的药物气雾制剂
JP2008534611A (ja) * 2005-03-30 2008-08-28 シェーリング コーポレイション 抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法
WO2006114379A1 (de) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
CA2619402C (en) 2005-08-15 2015-02-03 Boehringer Ingelheim International Gmbh Method for producing betamimetics
WO2009052624A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
LT2435025T (lt) 2009-05-29 2016-09-26 Pearl Therapeutics, Inc. Veikliosios medžiagos tiekimas per kvėpavimo takus
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
ES2693779T3 (es) 2012-12-21 2018-12-13 Boehringer Ingelheim Vetmedica Gmbh Ciclesonida para el tratamiento de enfermedades de las vías respiratorias en caballos
WO2014096116A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス,インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
HUE051527T2 (hu) * 2014-06-18 2021-03-01 Boehringer Ingelheim Vetmedica Gmbh Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003935D0 (en) * 2000-02-08 2000-04-12 King S College London Formulation for dry powder inhaler
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika

Also Published As

Publication number Publication date
MXPA05001823A (es) 2005-04-19
NZ538834A (en) 2007-10-26
KR20050051644A (ko) 2005-06-01
ATE366574T1 (de) 2007-08-15
DE50307659D1 (de) 2007-08-23
RU2005107475A (ru) 2006-04-10
DK1530471T3 (da) 2007-10-22
CY1107742T1 (el) 2013-04-18
CA2495454C (en) 2011-09-06
EP1785136A3 (de) 2009-04-22
PL212070B1 (pl) 2012-08-31
CA2495454A1 (en) 2004-03-18
EP1530471A1 (de) 2005-05-18
IL166891A (en) 2010-04-15
PT1530471E (pt) 2007-07-26
WO2004022058A1 (de) 2004-03-18
CO5540380A2 (es) 2005-07-29
KR101083977B1 (ko) 2011-11-22
ES2290549T3 (es) 2008-02-16
PL375233A1 (en) 2005-11-28
CN1688308A (zh) 2005-10-26
EP1530471B1 (de) 2007-07-11
EP1785136A2 (de) 2007-05-16
BR0313526A (pt) 2005-06-28
JP2006501253A (ja) 2006-01-12
AU2003255289B2 (en) 2009-08-20
DE10237739A1 (de) 2004-02-26
AU2003255289A1 (en) 2004-03-29
RU2332217C2 (ru) 2008-08-27

Similar Documents

Publication Publication Date Title
CA2455167C (en) New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US7244742B2 (en) Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US20060057074A1 (en) Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
CA2495454C (en) Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics
CA2431565C (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
US20100330186A1 (en) Medicaments for inhalation comprising an anticholinergic and a betamimetic
ZA200600372B (en) Medicaments for inhalation comprising betamimetics and an anticholinergic
ZA200302921B (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts.
CA2582207A1 (en) Inhalation medicament containing an anticholinesterase drug, salmeterol and a steroid selected from the ciclesonide or mometasone furoate group
CA2573370A1 (en) Inhalable medicaments containing corticosteroids, betamimetic and an anticholinergenic
EP1778230A2 (en) Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
EP1843764B1 (en) Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
CA2481268C (en) Medicaments comprising steroids and a novel anticholinergic
US20060239908A1 (en) Compositions for inhalation
AU2004262901B2 (en) Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
CA2533791C (en) Medicaments for inhalation comprising betamimetics and an anticholinergic agent
CA2436510A1 (en) Pharmaceutical compositions with few side effects
CA2582153A1 (en) Inhalation medicament containing a novel anticholinesterase drug, formoterol and a steroid
CA2635649A1 (en) New pharmaceutical compositions based on anticholinergics and andolast